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Introduction {#s1}
============

Air pollution is a well-established risk factor for adverse respiratory outcomes, including chronic lung diseases ([@c6]; [@c36]; [@c41]; [@c55]; [@c59]), hospitalizations ([@c19]) and death ([@c20]; [@c49]). Most recently, it has been estimated that for 2013 worldwide ambient particulate matter (PM) pollution accounts for nearly 170,000 deaths and nearly 4 million disability-adjusted life years (DALYs) due to chronic respiratory disease ([@c22]; [@c33]).

A common sequela of chronic lung disease is the development of pulmonary hypertension and impairments to the heart, including right ventricular (RV) dysfunction ([@c24]). The right ventricle pumps blood through the lungs to allow for its oxygenation. Then the oxygen-rich blood flows to the left ventricle for subsequent distribution to all tissues of the human body. Changes in RV structure and function can therefore result in many similar clinical sequelae of left ventricular (LV) changes, including dyspnea, exercise intolerance, lower-extremity edema, and (at advanced stages) severe heart failure ([@c62]). Although the left ventricle is vulnerable to increased pressures during ejection due to systemic hypertension or valvular disease, reduced blood supply, and hypoxia, the right ventricle may be similarly affected by changes in lung function \[e.g., chronic obstructive pulmonary disorder (COPD)\], LV function, and hypoxia (e.g., sleep disordered breathing). The RV has been thought to respond to this increased load through structural changes such as hypertrophy (i.e., thickening of the ventricle leading to increased mass), chamber dilation leading to greater end-diastolic volume, and lowered pumping efficiency (i.e., reduced ejection fraction) ([@c48]; [@c57]). Although these three manifestations of RV dysfunction are most likely in severe stages of lung disease, the right ventricle can also be affected early in lung disease ([@c30]). RV dysfunction has public health importance because it has been linked to poor outcomes among persons with and without preexisting disease, such as COPD and cardiovascular disease ([@c14]; [@c23]; [@c38]).

Long-term exposures to air pollution are believed to affect the same biological mechanisms that lead to COPD and cardiovascular disease. There is evidence that air pollution is associated with greater inflammation ([@c4]) and reduced vessel compliance ([@c11]; [@c39]; [@c44]); such evidence suggests a plausible link to RV function. In fact, two studies from the Multi-Ethnic Study of Atherosclerosis (MESA) recently linked long-term exposures to two combustion-related air pollutants: nitrogen dioxide ($\text{NO}_{2}$) ([@c40]) and fine PM (aerodynamic diameter $< 2.5\;\mu m$, $\text{PM}_{2.5}$) ([@c1]) to greater RV hypertrophy and lower function. Although PM in the coarse fraction (aerodynamic diameter between 2.5 and $10\;\mu m$, $\text{PM}_{10–2.5}$) has also been associated with adverse respiratory end points ([@c2]; [@c13]), no study has investigated associations between $\text{PM}_{10–2.5}$ and RV characteristics. Understanding the health impacts of $\text{PM}_{10–2.5}$ independent of other pollutants, including $\text{PM}_{2.5}$ and $\text{NO}_{2}$ has importance, given that the U.S. Environmental Protection Agency (EPA) is interested in regulating $\text{PM}_{10–2.5}$ levels but has struggled with insufficient data in the general population as well as among susceptible individuals ([@c61]). Because $\text{PM}_{10–2.5}$ is generated by very different diverse processes, ranging from crustal material to brake and tire wear, a lack of information on associations between health and indicators of different $\text{PM}_{10–2.5}$ sources represents another important gap in the literature.

To expand the literature on the health implications of $\text{PM}_{10–2.5}$ and to better understand environmental risk factors of RV dysfunction, we aimed to quantify cross-sectional associations between $\text{PM}_{10–2.5}$ and measures of RV function among older adults and susceptible subpopulations. We approached this goal using individual-level long-term estimates of $\text{PM}_{10–2.5}$ mass and selected source-specific components with multiple measures of RV structure (mass, end-diastolic volume) and function (ejection fraction) in participants of MESA. Some of these results have been previously reported in the form of an abstract ([@c3]).

Methods {#s2}
=======

Study Population {#s2.1}
----------------

Initiated in 2000, MESA is a multicenter, prospective study examining the progression of subclinical cardiovascular disease among an ethnically diverse population of 6,814 subjects (45--84 y old) who were free of known cardiovascular disease at baseline ([@c9]). In this analysis, we restricted reporting to participants from Chicago, Illinois, St. Paul, Minnesota, and Winston-Salem, North Carolina, who were part of the MESA Coarse ancillary study ($n = 3,295$). The MESA Coarse study conducted intensive sampling of $\text{PM}_{10–2.5}$ concentrations in three of the MESA sites chosen to reflect $\text{PM}_{10–2.5}$ variability. We further restricted to those who had cardiac magnetic resonance images (MRI) interpreted for RV morphology as part of the MESA RV ancillary study ($n = 1,851$). After excluding those with missing exposures and covariates, our final sample was 1,490 persons (Figure S1).

All protocols described herein received approval from local and national institutional review boards. Participants also provided informed consent.

Right Ventricle Characteristics {#s2.2}
-------------------------------

The MESA RV study obtained measures of RV function using cardiac MRIs performed at the baseline exam ([@c46]). These measures include RV mass at end-diastole, end-diastolic volume, and ejection fraction ([@c10]; [@c16]). These measures were estimated by two independent analysts using QMASS software (version 4.2; Medis), is described elsewhere ([@c16]). Based on random, blinded rereads from approximately 230 scans, the inter-reader intraclass correlation coefficients were 0.89, 0.96, and 0.80 for RV mass, end-diastolic volume, and ejection fraction, respectively ([@c37]).

Exposure Assessment {#s2.3}
-------------------

We used site-specific land-use regression spatial prediction models derived from project-specific $\text{PM}_{10–2.5}$ measurements and geographic data to predict concentrations of $\text{PM}_{10–2.5}$ at subjects' residences. Details of these models have been previously published ([@c66]). Briefly, we conducted two spatially intensive 2-wk monitoring campaigns of integrative $\text{PM}_{10}$ and $\text{PM}_{2.5}$ samples using paired Harvard Personal Exposure Monitors (HPEMs) in each of three MESA Coarse sites. In each city, approximately 60 locations were targeted to cover the greatest geographic space. Additionally, the locations were selected to capture the variability of hypothesized characteristics associated with $\text{PM}_{10–2.5}$ mass and components (e.g., vegetation, distance to roads). All samples were weighed in a temperature- and relative humidity-controlled chamber, analyzed for elements by X-ray fluorescence spectroscopy, and total $\text{PM}_{10–2.5}$ mass and that of chemical components were calculated by difference ([@c61]). The specific components of interest were copper, zinc, phosphorus, and silicon as consistent indicators for motor vehicle brake wear, tire wear, fertilized soil/agriculture, and crustal material across all study sites, respectively ([@c58]). We also examined a fifth component of $\text{PM}_{10–2.5}$, endotoxin, a major component of the outer membrane of Gram-negative bacteria. Endotoxin was chosen due to its capability to induce inflammation and modulate immune responses ([@c27]) and its association with airway disease ([@c56]). We separately derived spatial prediction models for $\text{PM}_{10–2.5}$ mass and each component using many geographic variables, including land use, population density, vegetation, impervious surface, roadways, railways, and airports, as well as spatial correlation. The cross-validated (CV) $R^{2}$ for the site-specific models of $\text{PM}_{10–2.5}$ and chemical species ranged from 0.3 to 0.9. As described elsewhere ([@c66]), the models performed best for copper (CV $R^{2}$, 0.5--0.9) and generally worse for endotoxin (CV $R^{2} = 0.3–0.4$). For our statistical modeling, we selected 5--y average concentrations weighted according to subjects' residential history preceding subjects' MRI.

Exposures to $\text{PM}_{2.5}$ and $\text{NO}_{2}$ were also estimated for each participant using spatiotemporal models derived from project-specific measurements, land-use characteristics, as well as regulatory monitoring data in the MESA Air study ([@c26]; [@c60]).

Covariates {#s2.4}
----------

All covariates, with the exception of airflow limitation, were assessed at baseline. These included sociodemographic and behavior information obtained via interview, and anthropometric measurements, left ventricle function, and laboratory data from the clinical exam. Comorbidities of hypertension and diabetes were also defined based on blood pressure or glucose measurements, respectively, self-reported medication use, and doctor diagnosis ([@c25]; [@c35]). Through the MESA Lung ancillary study, we had data on percent emphysema from computed tomography (CT) scans ([@c31]) and spirometry ([@c29]). The MESA Neighborhood Study developed a neighborhood socioeconomic scale (NSES) for each participant based on a principal components analysis of 2000 census tract data ([@c67]), including median household income, percent of persons in tract with at least a high school degree and median home value ([@c28]).

Statistical Analysis {#s2.5}
--------------------

Multivariable linear regression models were used to quantify adjusted cross-sectional associations between $\text{PM}_{10–2.5}$ and continuous measures of our RV outcomes. All models were adjusted for age, race/ethnicity (White, Chinese, Black, and Hispanic), sex, education (less than high school, high school/some college, college or more), NSES, height, weight, cigarette smoking history (never, former, current), pack-years of smoking (0 pack-y, $0 < \text{pack} - \text{y} \leq 10$, $10 < \text{pack} - \text{y} \leq 20$, greater than 20), second-hand smoke exposure, hypertension ([@c35]), diabetes (according to the 2003 American Diabetes Association Fasting Criteria Algorithm: normal, impaired fasting glucose, untreated diabetes, treated diabetes), cholesterol, study site, and an interaction of study site with NSES. Age, height, weight, NSES, and cholesterol were modeled as continuous; all other variables were modeled as categorical. In secondary models, we examined the linearity of these associations using splines and the robustness of our results to adjustment for $\text{PM}_{2.5}$ and $\text{NO}_{2}$ in two pollutant models. In secondary models of the chemical species of $\text{PM}_{10–2.5}$ we also adjusted for total mass as a covariate using a constituent residual model ([@c45]). We used interaction terms to assess effect modification by age, sex, race/ethnicity, smoking status, emphysema (defined as percent of emphysema-like lung based on CT scans that were greater than the upper limit of normal ([@c32])), and airflow limitation ($\text{FEV}_{1}/\text{FVC} < 0.7$). All reported estimates were scaled to the interquartile range (IQR) for each pollutant/species: $\text{PM}_{10–2.5}$ ($2.2{\,\mu g/m}^{3}$), copper ($4{\,\text{ng}/m}^{3}$), zinc ($11{\,\text{ng}/m}^{3}$), phosphorous ($6{\,\text{ng}/m}^{3}$), silicon ($0.13{\,\mu g/m}^{3}$), endotoxin ($0.08{\,\text{EU}/m}^{3}$), $\text{NO}_{2}$ (7.0 ppb), and $\text{PM}_{2.5}$ ($3.8{\,\mu g/m}^{3}$).

In sensitivity analyses, we restricted our analyses to participants who were residentially stable (lived at their current residence for 10 y or longer) and examined additional control for hypertension, diabetes, and cholesterol, as well as measures of LV function and lung disease as potential mediators.

The data analysis for this paper was generated using SAS (version 9.4; SAS Institute Inc.) and R (version 3.3.2; R Development Core Team).

Results {#s3}
=======

The mean age of the sample at baseline was 61 y; nearly 9% had physician-diagnosed asthma, and 7% had emphysema based on their CT scans ([Table 1](#t1){ref-type="table"}). Although participants in this sample were more likely to be Chinese, less likely to be black, and more likely to have a graduate degree than the full MESA Coarse cohort, these individuals were otherwise quite similar. Importantly, they did not differ with respect to their air pollution levels for all pollutants except zinc, which was approximately 10% lower in the study sample (Table S1).

###### 

Descriptive characteristics of the MESA Coarse participants at the baseline examination (2000--2002), by study site.

Table 1 lists descriptive characteristics in the first column; the corresponding values in total and for Winston-Salem, St. Paul, and Chicago are listed in the other columns separately.

  Characteristics                                                        Total              Winston-Salem      St. Paul           Chicago
  ---------------------------------------------------------------------- ------------------ ------------------ ------------------ ------------------
  $n$                                                                    1490               457                536                497
                                                                         $61.1 \pm 10.0$    $62.4 \pm 9.6$     $59.4 \pm 10.0$    $61.9 \pm 10.1$
  Age (y, %)                                                                                                                       
   45--54                                                                477 (32%)          124 (27%)          196 (37%)          157 (32%)
   55--64                                                                437 (29%)          128 (28%)          173 (32%)          136 (27%)
   65--74                                                                404 (27%)          150 (33%)          119 (22%)          135 (27%)
   75--84                                                                172 (12%)          55 (12%)           48 (9%)            69 (14%)
  Female                                                                 795 (53%)          253 (55%)          278 (52%)          264 (53%)
  Race/ethnicity                                                                                                                   
   White                                                                 828 (56%)          277 (61%)          327 (61%)          224 (45%)
   Chinese                                                               158 (11%)          0 (0%)             0 (0%)             158 (32%)
   Black                                                                 293 (20%)          178 (39%)          0 (0%)             115 (23%)
   Hispanic                                                              211 (14%)          2 (0%)             209 (39%)          0 (0%)
  Education                                                                                                                        
   $< \text{High}\,\text{school}$                                        400 (27%)          128 (28%)          205 (38%)          67 (13%)
   High school/some college                                              440 (30%)          135 (30%)          191 (36%)          114 (23%)
   $\geq \text{College}$                                                 650 (44%)          194 (42%)          140 (26%)          316 (64%)
  Smoking status                                                                                                                   
   Never                                                                 744 (50%)          225 (49%)          255 (48%)          264 (53%)
   Former                                                                556 (37%)          171 (37%)          200 (37%)          185 (37%)
   Current                                                               190 (13%)          61 (13%)           81 (15%)           48 (10%)
  $\geq 10\,\text{y}$ in neighborhood                                    1033 (69%)         281 (61%)          381 (71%)          371 (75%)
  Health                                                                                                                           
   BMI (${{kg}/m}^{2}$)                                                  $27.7 \pm 5.0$     $28.2 \pm 5.0$     $28.9 \pm 4.9$     $26.0 \pm 4.7$
   Cholesterol (mg/dl)                                                   $195.3 \pm 36.0$   $189.1 \pm 34.7$   $201.5 \pm 38.9$   $194.2 \pm 32.7$
   Hypertension                                                          584 (39%)          232 (51%)          167 (31%)          185 (37%)
   Diabetic                                                              2.3 (1.0)          1.4 (1.0)          2.0 (1.0)          3.8 (1.0)
   % Emphysema ($- 950\,\text{HU}$)[^*a*^](#t1n1){ref-type="table-fn"}   81% (0)            37% (0)            71% (0)            134% (0)
   Airflow limitation[^*b*^](#t1n2){ref-type="table-fn"}                 220 (22%)          66 (26%)           57 (19%)           97 (22%)
   Emphysema                                                             97 (7%)            15 (3%)            46 (9%)            36 (7%)
   Asthma                                                                130 (9%)           36 (8%)            51 (10%)           43 (9%)
   Left Ventricular end-diastolic Mass (g)                               $147.5 \pm 39.0$   $145.7 \pm 38.5$   $154.6 \pm 38.5$   $141.4 \pm 38.8$
  RV Outcomes                                                                                                                      
   RV mass (g)                                                           $21.6 \pm 4.7$     $21.2 \pm 4.3$     $22.7 \pm 4.9$     $20.8 \pm 4.5$
   RV ejection fraction (%)                                              $70.3 \pm 6.7$     $69.1 \pm 7.0$     $70.2 \pm 6.3$     $71.4 \pm 6.5$
   RV end-diastolic volume (mL)                                          $127.6 \pm 33.2$   $122.9 \pm 30.5$   $135.1 \pm 35.0$   $123.9 \pm 32.2$
  Pollutants                                                                                                                       
    $\text{PM}_{10–2.5}$ (${\mu g/m}^{3}$)                               $4.9 \pm 1.6$      $3.7 \pm 1.2$      $5.3 \pm 1.8$      $5.5 \pm 1.2$
    Copper (${\text{ng}/m}^{3}$)                                         $4.4 \pm 2.5$      $2.5 \pm 0.8$      $3.5 \pm 0.8$      $7.1 \pm 2.4$
    Zinc (${\text{ng}/m}^{3}$)                                           $9.0 \pm 9.6$      $3.1 \pm 1.6$      $5.1 \pm 1.2$      $18.5 \pm 11.5$
    Silicon (${\mu g/m}^{3}$)                                            $0.4 \pm 0.1$      $0.4 \pm 0.0$      $0.5 \pm 0.1$      $0.4 \pm 0.1$
    Phosphorous (${\text{ng}/m}^{3}$)                                    $15.9 \pm 3.6$     $19.7 \pm 2.2$     $12.9 \pm 1.9$     $15.6 \pm 2.7$
    Endotoxin (${\text{EU}/m}^{3}$)                                      $0.1 \pm 0.1$      $0.0 \pm 0.0$      $0.1 \pm 0.0$      $0.0 \pm 0.1$
    $\text{PM}_{2.5}$ (${\mu g/m}^{3}$)                                  $14.6 \pm 2.1$     $15.5 \pm 0.9$     $12.3 \pm 1.4$     $16.1 \pm 1.4$
    $\text{NO}_{2}$ (ppb)                                                $14.7 \pm 5.1$     $10.3 \pm 2.5$     $13.5 \pm 2.2$     $20.2 \pm 4.1$

Note: Values given as $n$ (%) or $\text{mean} \pm \text{standard}\,\text{deviation}$. BMI, body mass index; $\text{NO}_{2}$, nitrogen dioxide; $\text{PM}_{2.5}$, particulate matter $< 2:5\;\mu m$ in diameter; $\text{PM}_{10–2.5}$, particulate matter between 2.5 and $10\;\mu m$ in diameter; RV, right ventricular.

Emphysema is defined as the percent emphysema via computed tomography scan greater than the upper limit of normal.

Airflow limitation is defined as an $\text{FEV}_{1}/\text{FVC} < 0.7$ and was available on only 974 participants.

Average $\text{PM}_{10–2.5}$ mass concentrations were lowest for Winston-Salem ($3.7{\,\mu g/m}^{3}$) but similar in St. Paul ($5.3{\,\mu g/m}^{3}$) and Chicago ($5.5{\,\mu g/m}^{3}$). St. Paul had the largest intracity variation (standard deviation: $1.8{\,\mu g/m}^{3}$ in St. Paul vs. $1.2{\,\mu g/m}^{3}$ for Chicago and Winston-Salem). With respect to the chemical components, the highest average concentrations of the two traffic-related markers of copper and zinc were in Chicago, whereas Winston-Salem had the highest concentrations of phosphorus. Mean endotoxin levels were generally low ($\leq 0.1{\,\text{EU}/m}^{3}$) across all locations. In all locations, we observed modest to high correlations (0.46--0.89) between the traffic-related pollutants of copper, zinc, and $\text{NO}_{2}$. In addition, $\text{PM}_{2.5}$ and $\text{NO}_{2}$ were also correlated ($> 0.6$) in all locations. Although the other pollutants did not demonstrate consistent patterns across sites, there were notable ($> 0.6$) correlations between most pollutants in Chicago (Table S2).

Among all participants, RV mass was positively associated with $\text{PM}_{10–2.5}$ mass, copper, phosphorus, and silicon in single-pollutant models ([Table 2](#t2){ref-type="table"}). After controlling for $\text{PM}_{2.5}$ and $\text{NO}_{2}$, however, which were themselves associated with RV mass, the association with copper was eliminated and associations with $\text{PM}_{10–2.5}$ mass, phosphorus, and silicon were blunted. Apart from copper, adjustment for $\text{PM}_{10–2.5}$ mass did not strongly affect associations with any chemical components (Figure S2). Results were also robust to more and less control for potential intermediate factors such as hypertension, cholesterol, diabetes, emphysema, airflow limitation, and LV mass and function (Figure S3).

###### 

Associations between $\text{PM}_{10–2.5}$ mass and RV structure and function in single and multipollutant models.

Table 2 lists Model in the first column; the corresponding difference, 95 percent confidence interval, and p-value for mass (g), volume (mL), and ejection fraction (%) are listed in the other columns separately.

  Model                          Mass (g)  Volume (mL)    Ejection Fraction (%)                                                            
  ----------------------------- ---------- -------------- ----------------------- --------- -------------- ------ --------- -------------- ------
  $\text{PM}_{10–2.5}$                                                                                                                      
   Single Pollutant Model          0.3     0.0, 0.5       0.06                       0.4    $- 1.3$, 2.2   0.63    $- 0.1$  $- 0.6$, 0.4   0.75
   $+ {\,\text{PM}}_{2.5}$         0.2     $- 0.1$, 0.5   0.14                       0.3    $- 1.5$, 2.2   0.74    $- 0.1$  $- 0.6$, 0.4   0.76
   $+ {\,\text{NO}}_{2}$           0.2     $- 0.1$, 0.5   0.22                       0.4    $- 1.5$, 2.3   0.68    $- 0.1$  $- 0.6$, 0.4   0.72
  Cu                                                                                                                                        
   Single Pollutant Model          0.3     $- 0.2$, 0.8   0.20                       0.6    $- 2.5$, 3.6   0.71      0.1    $- 0.7$, 1.0   0.75
   $+ {\,\text{PM}}_{2.5}$         0.0     $- 0.5$, 0.5   0.93                       0.0    $- 3.4$, 3.3   0.99      0.5    $- 0.5$, 1.4   0.32
   $+ {\,\text{NO}}_{2}$         $- 0.2$   $- 0.8$, 0.5   0.56                     $- 0.1$  $- 4.3$, 4.1   0.96      0.4    $- 0.8$, 1.6   0.56
  Zn                                                                                                                                        
   Single Pollutant Model          0.0     $- 0.3$, 0.3   0.90                     $- 0.6$  $- 2.6$, 1.3   0.51    $- 0.1$  $- 0.6$, 0.5   0.81
   $+ {\,\text{PM}}_{2.5}$       $- 0.2$   $- 0.5$, 0.1   0.16                     $- 1.1$  $- 3.2$, 0.9   0.27      0.1    $- 0.5$, 0.6   0.85
   $+ {\,\text{NO}}_{2}$         $- 0.3$   $- 0.7$, 0.0   0.09                     $- 1.4$  $- 3.6$, 0.9   0.24    $- 0.1$  $- 0.7$, 0.6   0.81
  P                                                                                                                                         
   Single Pollutant Model          0.5     0.0, 1.0       0.03                       0.5    $- 2.6$, 3.6   0.75    $- 0.1$  $- 0.9$, 0.8   0.87
   $+ {\,\text{PM}}_{2.5}$         0.2     $- 0.3$, 0.7   0.41                     $- 0.4$  $- 3.6$, 2.9   0.83      0.0    $- 0.9$, 1.0   0.93
   $+ {\,\text{NO}}_{2}$           0.3     $- 0.2$, 0.8   0.25                       0.0    $- 3.4$, 3.4   0.99    $- 0.1$  $- 1.0$, 0.9   0.91
  Si                                                                                                                                        
   Single Pollutant Model          0.4     0.1, 0.7       0.01                       0.8    $- 1.1$, 2.8   0.41    $- 0.2$  $- 0.7$, 0.4   0.54
   $+ {\,\text{PM}}_{2.5}$         0.2     $- 0.2$, 0.5   0.36                       0.2    $- 2.0$, 2.4   0.86      0.0    $- 0.6$, 0.6   0.95
   $+ {\,\text{NO}}_{2}$           0.3     $- 0.1$, 0.6   0.19                       0.7    $- 1.8$, 3.1   0.59    $- 0.2$  $- 0.9$, 0.4   0.49
  Endotoxin                                                                                                                                 
   Single Pollutant Model        $- 0.1$   $- 0.5$, 0.2   0.49                     $- 0.2$  $- 2.4$, 1.9   0.82    $- 0.1$  $- 0.7$, 0.5   0.67
   $+ {\,\text{PM}}_{2.5}$         0.1     $- 0.3$, 0.4   0.64                       0.1    $- 2.1$, 2.4   0.91    $- 0.4$  $- 1.0$, 0.3   0.26
   $+ {\,\text{NO}}_{2}$           0.0     $- 0.4$, 0.3   0.89                     $- 0.1$  $- 2.4$, 2.1   0.90    $- 0.2$  $- 0.8$, 0.5   0.59
  $\text{NO}_{2}$                                                                                                                           
   Single Pollutant Model          0.5     0.1, 0.9       0.01                       0.8    $- 1.8$, 3.5   0.54      0.0    $- 0.8$, 0.7   0.93
   $+ {\,\text{PM}}_{10–2.5}$      0.4     0.0, 0.9       0.06                       0.6    $- 2.2$, 3.5   0.66      0.0    $- 0.8$, 0.8   0.96
   $+ {\,\text{PM}}_{2.5}$         0.2     $- 0.3$, 0.8   0.38                       0.3    $- 3.1$, 3.8   0.84      0.3    $- 0.7$, 1.3   0.53
  $\text{PM}_{2.5}$                                                                                                                         
   Single Pollutant Model          1.0     0.4, 1.6       0.001                      1.8    $- 2.0$, 5.6   0.36    $- 0.6$  $- 1.7$, 0.4   0.25
   $+ {\,\text{PM}}_{10–2.5}$      0.9     0.3, 1.5       0.003                      1.7    $- 2.3$, 5.6   0.41    $- 0.6$  $- 1.7$, 0.5   0.28
   $+ {\,\text{NO}}_{2}$           0.8     0.0, 1.5       0.043                      1.5    $- 3.4$, 6.4   0.56    $- 0.9$  $- 2.3$, 0.5   0.19

Note: All models adjusted for age, race, gender, height, weight, neighborhood socioeconomic scale (NSES), NSES, education, smoking status, pack-years, second-hand smoke exposure, hypertension, diabetes, total cholesterol, study site, and site by NSES interaction. Associations scaled to interquartile range (IQR) IQR of pollutant: $\text{PM}_{10–2.5}$ ($2.2{\,\mu g/m}^{3}$), Cu ($4{\,\text{ng}/m}^{3}$), Zn ($11{\,\text{ng}/m}^{3}$), P ($6{\,\text{ng}/m}^{3}$), Si ($0.13{\,\mu g/m}^{3}$), endotoxin ($0.08{\,\text{EU}/m}^{3}$), $\text{PM}_{2.5}$ ($3.8{\,\mu g/m}^{3}$), $\text{NO}_{2}$ ($7.0\,\text{ppb}$). CI, confidence interval; Cu, copper; $\text{NO}_{2}$, nitrogen dioxide; P, phosphorous; $\text{PM}_{2.5}$, particulate matter $< 2:5\;\mu m$ in diameter; $\text{PM}_{10–2.5}$, particulate matter between 2.5 and $10\;\mu m$ in diameter; Si, silicon; Zn, zinc.

Analysis of effect modification suggested that associations between $\text{PM}_{10–2.5}$ and RV mass were present in several susceptible populations. These subgroups included: former and current smokers in comparison with nonsmokers ($p - \text{value}\,\text{for}\,\text{interaction} = 0.02$), persons with emphysema in comparison with persons without emphysema ($p - \text{value}\,\text{for}\,\text{interaction} = 0.02$), and residentially stable participants in comparison with participants who had lived at their residences for less than 10 y ($p - \text{value}\,\text{for}\,\text{interaction} = 0.15$). These associations remained even after adjustment for $\text{PM}_{2.5}$ and $\text{NO}_{2}$ concentrations ([Figure 1](#f1){ref-type="fig"}) and after adjustment for emphysema (results not shown).

![Effect modification of associations between $\text{PM}_{10–2.5}$ concentrations and RV end-diastolic mass after control for $\text{PM}_{10–2.5}$ and $\text{NO}_{2}$ \[g per interquartile range (IQR) of pollutant, 95% confidence interval (CI)\].\
\*Interaction was statistically significant ($p < 0.05$). Note: $\text{PM}_{2.5}$, particulate matter with aerodynamic diameter between 2.5 and $10\;\mu m$; $\text{NO}_{2}$, nitrogen dioxide.](EHP658_f1){#f1}

Although the size and direction of the associations between $\text{PM}_{10–2.5}$ mass and silicon with RV end-diastolic volume were consistent with RV mass, the confidence intervals were very wide and indistinguishable from no association ([Table 2](#t2){ref-type="table"}). As with RV mass, associations with RV end-diastolic volume were strongest among current smokers, participants with emphysema, and particpants who were residentially stable, although the precision of these estimates remained large (Figure S4). No associations were observed with ejection fraction in the full cohort or in any subpopulation evaluated.

Discussion {#s4}
==========

Among a population-based cohort from three U.S. metropolitan areas, we found suggestive evidence of associations between $\text{PM}_{10–2.5}$ and RV structure after adjustment for confounding by $\text{PM}_{2.5}$ and $\text{NO}_{2}$. Positive associations between total $\text{PM}_{10–2.5}$ mass concentrations and RV hypertrophy and, to a lesser extent, dilation were driven by relationships among former and current smokers, persons with advanced emphysema, and participants who were residentially stable. Associations were not found among other participants. No associations were found with RV ejection fraction among any group.

This study adds to the literature by expanding our understanding of the health implications of $\text{PM}_{10–2.5}$ and the environmental risk factors for RV dysfunction. After adjustment for other risk factors such as smoking, height, weight, and co-pollutants previously associated with RV dysfunction, we observed the most robust associations for $\text{PM}_{10–2.5}$ mass with a $1.4\; g$ (95% CI: 0.4, 2.5) and $0.9\; g$ (95% CI: 0.1, 1.7) larger RV mass among persons with emphysema and current smokers, respectively, per $2.2{\,\mu g/m}^{3}$. These associations were on the same order of magnitude as those reported for $\text{PM}_{2.5}$ in the full cohort ([@c1]) and in the MESA Coarse cities. These differences are also comparable to differences in RV mass for participants $5{\,{kg}/m}^{2}$ apart in BMI ([@c17]) and may be clinically relevant, given that MESA participants with RV hypertrophy have double to triple the risk of heart failure or cardiovascular death ([@c38]).

Mechanisms through which $\text{PM}_{10–2.5}$ exposures might likely affect the right ventricle ([@c62]) include the restructuring of the pulmonary vasculature, increases in RV load ([@c65]), hypoxia, inflammation ([@c18]), and autonomic dysfunction ([@c63]; [@c64]). Support for these mechanisms comes from a previous study of healthy Mexican children that reported greater pulmonary arterial pressures and serum levels of the vasoconstrictive protein endothelin-1 with larger long-term PM concentrations ([@c15]). Toxicological research has similarly demonstrated enhanced vasoconstriction and impaired vasodilation of pulmonary arterioles in healthy animals and in animals with chronic bronchitis exposed to PM ([@c21]; [@c47]). Interestingly, the associations with RV mass were robust to control for hypertension, emphysema, airflow limitation, and LV mass and function, suggesting that these factors may not be critical intermediates of our observed associations. However, it is difficult to conclusively assess mediation in this study given our cross-sectional design and the possibility that only advanced cases of emphysema or airflow limitation are critical intermediates, which are limited in number in this population. Our overall null associations with RV ejection fraction were similar to findings in a previous analysis ([@c38]) where only RV mass was independently associated with cardiovascular death. These data could suggest that RV hypertrophy is an earlier indicator of increased pressure in the RV than RV ejection fraction, though this has yet to be clearly demonstrated.

Although the observed association between $\text{PM}_{10–2.5}$ and RV appeared to be independent of $\text{PM}_{10–2.5}$-associated lung damage, the interaction with emphysema suggests that individuals with preexisting lung damage may be more susceptible to long-term $\text{PM}_{10–2.5}$ exposures. This susceptibility is plausible, given that persons with COPD have greater deposition and less mucociliary clearance of particles from their lungs relative to healthy individuals ([@c8]; [@c12]). It is also consistent with epidemiological evidence of enhanced vulnerability of persons with respiratory conditions to short-term air pollution exposures ([@c21]; [@c47]; [@c54]), though the findings of the few studies to examine chronic lung disease as an effect modifier of long-term exposures to air pollution have been mixed ([@c7]; [@c34]).

We also observed positive associations between RV mass and $\text{PM}_{10–2.5}$ concentrations among participants who smoke or who have a history of smoking, independent of their emphysema status. One possible explanation may be that individuals who smoke or have smoked are more susceptible to the effects of air pollution because of smoking's ability to increase inflammation and vasoconstriction ([@c5]) and alter immune function, among other effects. However, epidemiologic evidence has also been mixed regarding the interaction between smoking and air pollution ([@c50]), suggesting that more research is necessary to understand this relationship. In addition, some caution is warranted about the generalizability of these findings as the smokers in MESA are generally healthier than the average smoking population due to our restriction to older adults without cardiovascular disease at baseline.

Our study is not without limitations. First, due to its cross-sectional design, our findings only provide evidence of potential associations that warrant further evaluation. Reverse causality is unlikely, however, and we have adjusted our models for a rich set of personal characteristics to account for between-person differences. Second, despite the highly innovative exposure assessment used, our exposure models are entirely spatial in nature and are assumed to capture the key differences in concentrations across space at different times. Our finding that associations were larger and more precise among persons living at their residences for $> 10\,\text{y}$ may, however, suggest that our overall results may be biased towards the null due to inaccuracies in long-term exposures for some participants. On the other hand, compared with individuals who lived in their neighborhood for $< 10\,\text{y}$, residentially stable participants were more likely to be older, have hypertension, and have advanced emphysema, suggesting that these individuals may have been susceptible for other reasons. Another issue is that our models varied in predictive power by pollutant. Thus, differences in the observed strength of association between pollutants may be causal or could simply reflect different measurement errors. For example we found significant associations with $\text{PM}_{2.5}$ and $\text{NO}_{2}$, which, compared with $\text{PM}_{10–2.5}$, had substantially better predictive ability due to a greater number of measurements that were collected over a longer period of time. In contrast, no associations were found with endotoxin, which had the lowest $\text{CV}\, R^{2}$ in our prediction models. This finding may be the result of smaller errors for $\text{PM}_{2.5}$ and $\text{NO}_{2}$ that make them less likely to be biased toward the null in individual pollutant and multipollutant models. Finally, although the exposure estimation methods used in this study allow for individual assessment of outdoor concentrations, we do not have estimates of indoor or personal concentrations.

Despite these limitations, this work has many important strengths. The MESA cohort is an extremely well-characterized population with detailed and standardized measures of outcomes and covariates. The availability of RV measures is unique in such a large sample. Another distinction in this study is our exposure assessment, which improves on existing epidemiology studies of long-term exposures to $\text{PM}_{10–2.5}$ in the United States. Our model predicts fine-scale spatial variability in exposures using a model derived from intensive air pollution monitoring campaigns in each study community. This methodology is in contrast to previous studies that have relied exclusively on data from relatively sparse national monitoring networks to estimate exposures to $\text{PM}_{10–2.5}$ ([@c42]; [@c43]; [@c49]; [@c51]; [@c52]). We were also able to control for copollutants ($\text{PM}_{2.5}$ and $\text{NO}_{2}$) and demonstrated independent associations with $\text{PM}_{10–2.5}$. The availability of chemical component data has particularly important implications for regulatory purposes, given that $\text{PM}_{10–2.5}$ is generated by both natural and anthropogenic sources. This inclusion has important implications for regulatory purposes, given that $\text{PM}_{10–2.5}$ is generated by both natural and anthropogenic sources.

Conclusion {#s5}
==========

This cross-sectional study provided some evidence of a positive association between long-term residential $\text{PM}_{10–2.5}$ concentrations and RV mass among persons with a history of tobacco-smoke exposures and persons with severe emphysema. If replicated by future work, our findings could suggest a possible mechanism for observed associations between $\text{PM}_{10–2.5}$ exposures and mortality from respiratory disease.
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